Green Cross Holdings Corporation (KRX:005250)
14,410
+10 (0.07%)
Feb 21, 2025, 9:00 AM KST
Green Cross Holdings Revenue
Green Cross Holdings had revenue of 609.98B KRW in the quarter ending September 30, 2024, with 12.60% growth. This brings the company's revenue in the last twelve months to 2.18T, up 7.84% year-over-year. In the year 2023, Green Cross Holdings had annual revenue of 2.06T, down -1.04%.
Revenue (ttm)
2,181.32B
Revenue Growth
+7.84%
P/S Ratio
0.30
Revenue / Employee
14.45B
Employees
151
Market Cap
654.24B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2,057.94B | -21.62B | -1.04% |
Dec 31, 2022 | 2,079.56B | 239.00B | 12.99% |
Dec 31, 2021 | 1,840.56B | 121.23B | 7.05% |
Dec 31, 2020 | 1,719.33B | 225.74B | 15.11% |
Dec 31, 2019 | 1,493.59B | -55.13B | -3.56% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |